Our Mission.

Provide clinically actionable results to personalize patient care in minutes instead of days

BLASTID is led by diagnostic veterans, esteemed clinicians, & world-renowned scientists. We close the gap between sample and answer to guide patient care, pioneering diagnostics that are faster, smarter, and clinically actionable. We are a driven team united to solve a problem that kills millions of people every year.

BLASTID spun out of Harvard to defeat antimicrobial resistance through transformative clinical solutions with support from the ARPA-H DARTS program.

Our Values

Data-Driven · Patient-Centric · Collaborative · Inclusive · Intentional · Resilient

Company Founders

  • Portrait of Paulo A. Garcia, Ph.D., Co-founder of BLASTID

    Paulo A. Garcia, Ph.D.

    CEO & President

    Board Director

  • Portrait of Johan Paulsson, Ph.D., Professor of Systems Biology at Harvard Medical School

    Johan Paulsson, Ph.D.

    Co-Founder

    Chair of Scientific Advisory Board

  • Portrait of Rahul Dhanda

    Rahul Dhanda

    Co-Founder

    Chair of the Board of Directors

The BLASTID Team

BLASTID's team brings together experience from across the diagnostics industry, diagnostic development, and clinical medicine.

Commercial & Operations

Research & Development

Product Development

Scientific Advisory Board

BLASTID's advisors span clinical infectious disease, advanced microscopy, novel microfluidics, computational biology, regulatory strategy, and regulated medical device development. 

Scientific Advisory Board

  • A woman with curly black hair smiling, wearing large round glasses, earrings, layered necklaces, and a white striped shirt.

    Dr. Johan Paulsson, Ph.D.

    FOUNDER & HEAD of SAB

    • Scientific Advisor

    • Professor of Systems Biology

    • Harvard Medical School

  • Dr. Eleftherios Mylonakis, MD, PhD, FIDSA

    Dr. Eleftherios Mylonakis, M.D., Ph.D., FIDSA

    CLINICAL COLLABORATOR

    • Chair of Department of Medicine

    • Houston Methodist Hospital

  • Dr. Roby Bhattacharyya, M.D., PhD, BLASTID | MGH

    Dr. Roby Bhattacharyya, M.D., Ph.D.

    CLINICAL COLLABORATOR

    • Harvard Medical School

    • Massachusetts General Hospital

    • The Broad Institute

  • Devon Campbell, MSc, Product development collaborator BLASTID blood diagnostics

    Devon Campbell, M.Sc.

    PRODUCT DEVELOPMENT COLLABORATOR

    • Founder, CEO, Prodct Studio

  • Christie Johnson

    Christie Johnson

    PRODUCT DEVELOPMENT COLLABORATOR

    • Founder, COO, Prodct Studio

  • Dr. Gail Radcliffe, Ph.D., Regulatory Advisor BLASTID blood diagnostics

    Dr. Gail Radcliffe, Ph.D.

    REGULATORY ADVISOR

    • Founder, Radcliffe Consulting

  • Dr. Jan Funke, PhD, Scientific Advisor, BLASTID blood diagnostics

    Dr. Jan Funke, Ph.D.

    SCIENTIFIC ADVISOR

    • Senior Group Leader, Computational Biology

    • Fondazione Human Technopole (Italy)

  • Dr. Laura Waller, PhD Regulatory advisor BLASTID blood diagnostics

    Dr. Laura Waller, Ph.D.

    SCIENTIFIC ADVISOR

    • Professor, Electrical Engineering and Computer Science

    • UC Berkeley

  • Dr. Harrison Steel, PhD, Scientific advisor BLASTID blood diagnostics

    Dr. Harrison Steel, Ph.D.

    SCIENTIFIC ADVISOR

    • Associate Professor of Engineering Science

    • University of Oxford

Careers at BLASTID

Interested in joining our team? Reach out.

We're always looking for talented, motivated individuals who are passionate about our mission. Even if a specific role that matches your background isn’t listed, we encourage you to reach out at careers@blastid.ai. If you're interested in making an impact and believe you'd be a great fit for our team, we'd love to hear from you.

BLASTID is an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or protected veteran status.

Connect with us.

BLASTID is working with hospital systems, clinical laboratories, and key stakeholders to bring culture-free, direct-from-blood diagnostics into routine practice.

Join us on the journey to unlock massive patient impact and commercial success.